100. de Wit LT, Mathus-Vliegen L, Hey C, Rademaker B, Gouma DJ, Obertop H. Open versus laparoscopic adjustable silicone gastric banding: a prospective randomized trial for treatment of morbid obesity. Ann Surg 1999;230:800-5; discussion 805-7.
101. Weiss HG, Nehoda H, Labeck B, et al. Adjustable gastric and esophagogastric banding: a randomized clinical trial. Obes Surg 2002;12:573-8.
102. Weiner R, Bockhorn H, Rosenthal R, Wagner D. A prospective randomized trial of different laparoscopic gastric banding techniques for morbid obesity. Surg Endosc 2001;15:63-8.
103. Sjostrom L, Larsson B, Backman L, et al. Swedish Obese Subjects (SOS). Recruitment for an intervention study and a selected description of the obese state. Int J Obes Relat Metab Disord 1992;16:465-79.
104. Torgerson JS, Sjostrom L. The Swedish Obese Subjects (SOS) study—rationale and results. Int J Obes Relat Metab Disord 2001;25(Suppl 1):S2-S4.
105. McMahon FG, Fujioka K, Singh BN, et al. Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trial. Arch Intern Med 2000;160:2185-91.
106. Sjostrom L, Rissanen A, Andersen T, et al. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group. Lancet 1998;352:167-72.
107. Hollander PA, Elbein SC, Hirsch IB, et al. Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study. Diabetes Care 1998;21:1288-94.
108. Lindgarde F. The effect of orlistat on body weight and coronary heart disease risk profile in obese patients: the Swedish Multimorbidity Study. J Intern Med 2000;248:245-54.
109. Rossner S, Sjostrom L, Noack R, Meinders AE, Noseda G. Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European Orlistat Obesity Study Group. Obes Res 2000;8:49-61.
110. Hauptman J, Lucas C, Boldrin MN, Collins H, Segal KR. Orlistat in the long-term treatment of obesity in primary care settings. Arch Fam Med 2000;9:160-7.
111. Scheen AJ, Lefebvre PJ. Pharmacological treatment of obesity: present status. Int J Obes Relat Metab Disord 1999;23(Suppl 1):47-53.
112. Luque CA, Rey JA. Sibutramine: a serotonin-norepinephrine reuptake-inhibitor for the treatment of obesity. Ann Pharmacother 1999;33:968-78.
113. Apfelbaum M, Vague P, Ziegler O, Hanotin C, Thomas F, Leutenegger E. Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine. Am J Med 1999;106:179-84.
114. Bray GA. Drug treatment of obesity. Baillieres Best Pract Res Clin Endocrinol Metab 1999;13:131-48.
115. Orlistat. No hurry.... Can Fam Physician 1999;45:2331-3, 2336-8, 2343-5 passim.
116. Finer N, James WP, Kopelman PG, Lean ME, Williams G. One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor. Int J Obes Relat Metab Disord 2000;24:306-13.
117. Sjostrom L. Surgical intervention as a strategy for treatment of obesity. Endocrine Journal-Uk 2000;13:213-30.
118. Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995;222:339-50; discussion 350-2.
119. Brolin RE, Bradley LJ, Wilson AC, Cody RP. Lipid risk profile and weight stability after gastric restrictive operations for morbid obesity. J Gastrointest Surg 2000;4:464-9.
120. Sjostrom CD, Lissner L, Wedel H, Sjostrom L. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes Res 1999;7:477-84.
121. Sjostrom CD, Peltonen M, Sjostrom L. Blood pressure and pulse pressure during long-term weight loss in the obese: the Swedish Obese Subjects (SOS) Intervention Study. Obes Res 2001;9:188-95.
122. Williamson DF, Pamuk E, Thun M, Flanders D, Byers T, Heath C. Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40-64 years. Am J Epidemiol 1995;141:1128-41.
123. Singh RB, Rastogi SS, Verma R, et al. Randomised controlled trial of cardioprotective diet in patients with recent acute myocardial infarction: results of one year follow up. BMJ 1992;304:1015-9.
124. Lissner L, Odell PM, D'Agostino RB, et al. Variability of body weight and health outcomes in the Framingham population. N Engl J Med 1991;324:1839-44.
125. Blair SN, Shaten J, Brownell K, Collins G, Lissner L. Body weight change, all-cause mortality, and cause-specific mortality in the Multiple Risk Factor Intervention Trial. Ann Intern Med 1993;119:749-57.
126. Andres R, Muller DC, Sorkin JD. Long-term effects of change in body weight on all-cause mortality. A review. Ann Intern Med 1993;119:737-43.
127. Williamson DF. "Weight cycling" and mortality: how do the epidemiologists explain the role of intentional weight loss? J Am Coll Nutr 1996;15:6-13.
128. Reynolds MW, Fredman L, Langenberg P, Magaziner J. Weight, weight change, mortality in a random sample of older community-dwelling women. J Am Geriatr Soc 1999;47:1409-14.
129. Williamson DF, Pamuk ER. The association between weight loss and increased longevity. A review of the evidence. Ann Intern Med 1993;119:731-6.
130. National Task Force on the Prevention and Treatment of Obesity. Weight cycling. JAMA 1994;272:1196-202.
131. Olson MB, Kelsey SF, Bittner V, et al. Weight cycling and high-density lipoprotein cholesterol in women: evidence of an adverse effect: a report from the NHLBI-sponsored WISE study. Women's Ischemia Syndrome Evaluation Study Group. J Am Coll Cardiol 2000;36:1565-71.
132. Guagnano MT, Ballone E, Pace-Palitti V, et al. Risk factors for hypertension in obese women. The role of weight cycling. Eur J Clin Nutr 2000;54:356-60.
133. Field AE, Wing RR, Manson JE, Spiegelman DL, Willett WC. Relationship of a large weight loss to long-term weight change among young and middle-aged US women. Int J Obes Relat Metab Disord 2001;25:1113-21.
134. Petersmarck KA, Teitelbaum HS, Bond JT, Bianchi L, Hoerr SM, Sowers MF. The effect of weight cycling on blood lipids and blood pressure in the Multiple Risk Factor Intervention Trial Special Intervention Group. Int J Obes Relat Metab Disord 1999;23:1246-55.
135. Bouchard C. Is weight fluctuation a risk factor? N Engl J Med 1991;324:1887-9.
136. Kuller L, Wing R. Weight loss and mortality. Ann Intern Med 1993;119:630-2.
137. Dellinger E. Variability of body weight and health outcomes (ed). N Engl J Med 1997;325:1745-6.
138. Gortmaker SL, Must A, Perrin JM, Sobol AM, Dietz WH. Social and economic consequences of overweight in adolescence and young adulthood. N Engl J Med 1993;329:1008-12.
139. Teachman BA, Brownell KD. Implicit anti-fat bias among health professionals: is anyone immune? Int J Obes Relat Metab Disord 2001;25:1525-31.
140. Myers A, Rosen JC. Obesity stigmatization and coping: relation to mental health symptoms, body image, and self-esteem. Int J Obes Relat Metab Disord 1999;23:221-30.
141. Knowler WC, Narayan KM, Hanson RL, et al. Preventing non-insulin-dependent diabetes. Diabetes 1995;44:483-8.
142. Arterburn D, Noel PH. Extracts from "Clinical Evidence" Obesity. BMJ 2001;322:1406-9.
143. Melissas J, Christodoulakis M, Spyridakis M, et al. Disorders associated with clinically severe obesity: significant improvement after surgical weight reduction. South Med J 1998;91:1143-8.
144. Schauer PR, Ikramuddin S, Gourash W, Ramanathan R, Luketich J. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg 2000;232:515-29.
145. Bloomston M, Zervos EE, Camps MA, Goode SE, Rosemurgy AS. Outcome following bariatric surgery in super versus morbidly obese patients: does weight matter? Obes Surg 1997;7:414-9.
146. Balsiger BM, Poggio JL, Mai J, Kelly KA, Sarr MG. Ten and more years after vertical banded gastroplasty as primary operation for morbid obesity. J Gastrointest Surg 2000;4:598-605.
147. Davila-Cervantes A, Ganci-Cerrud G, Gamino R, Gallegos-Martinez J, Gonzalez-Barranco J, Herrera MF. Open vs. laparoscopic vertical banded gastroplasty: a case control study with a 1-year follow-up. Obes Surg 2000;10:409-12.
148. Alper D, Ramadan E, Vishne T, et al. Silastic ring vertical gastroplasty-long-term results and complications. Obes Surg 2000;10:250-4.
149. Choi Y, Frizzi J, Foley A, Harkabus M. Patient satisfaction and results of vertical banded gastroplasty and gastric bypass. Obes Surg 1999;9:33-5.
150. Papakonstantinou A, Alfaras P, Komessidou V, Hadjiyannakis E. Gastrointestinal complications after vertical banded gastroplasty. Obes Surg 1998;8:215-7.
151. Baltasar A, Bou R, Arlandis F, et al. Vertical banded gastroplasty at more than 5 years. Obes Surg 1998;8:29-34.
152. Stoner J, Stoner P, Sytsma J. 42-month preliminary follow-up of the silastic ring vertical banded gastroplasty. Obes Surg 1997;7:513-5.
153. Yashkov YI, Timoshin AD, Oppel TA. Vertical banded gastroplasty: first experience in Russia. Obes Surg 1997;7:317-20; discussion 321.
154. Goulding ST, Hovell BC. Anaesthetic experience of vertical banded gastroplasty. Br J Anaesth 1995;75:301-6.
155. Lundell L, Ruth M, Olbe L. Vertical banded gastroplasty or gastric banding for morbid obesity: effects on gastro-oesophageal reflux. Eur J Surg 1997;163:525-31.
156. Nguyen NT, Ho HS, Palmer LS, Wolfe BM. A comparison study of laparoscopic versus open gastric bypass for morbid obesity. J Am Coll Surg 2000;191:149-55; discussion 155-7.
157. Choban PS, Onyejekwe J, Burge JC, Flancbaum L. A health status assessment of the impact of weight loss following Roux-en-Y gastric bypass for clinically severe obesity. J Am Coll Surg 1999;188:491-7.
158. Jones KB. Roux-en-Y gastric bypass: an effective antireflux procedure in the less than morbidly obese. Obes Surg 1998;8:35-8.
159. Crampton NA, Izvornikov V, Stubbs RS. Silastic ring gastric bypass: results in 64 patients. Obes Surg 1997;7:489-94.
160. Freeman JB, Kotlarewsky M, Phoenix C. Weight loss after extended gastric bypass. Obes Surg 1997;7:337-44.
161. Oh CH, Kim HJ, Oh S. Weight loss following transected gastric bypass with proximal Roux-en-Y. Obes Surg 1997;7:142-7; discussion 148.
162. Abu-Abeid S, Szold A. Laparoscopic management of Lap-Band erosion. Obes Surg 2001;11:87-9.
163. Nowara HA. Egyptian experience in laparoscopic adjustable gastric banding (technique, complications and intermediate results). Obes Surg 2001;11:70-5.
164. De Luca M, de Werra C, Formato A, et al. Laparotomic vs laparoscopic lap-band: 4-year results with early and intermediate complications. Obes Surg 2000;10:266-8.
165. Suter M, Bettschart V, Giusti V, Heraief E, Jayet A. A 3-year experience with laparoscopic gastric banding for obesity. Surg Endosc 2000;14:532-6.
166. Wiesner W, Schob O, Hauser RS, Hauser M. Adjustable laparoscopic gastric banding in patients with morbid obesity: radiographic management, results, and postoperative complications. Radiology 2000;216:389-94.
167. Holeczy P, Novak P, Kralova A. Complications in the first year of laparoscopic gastric banding: is it acceptable? Obes Surg 1999;9:453-5.
168. Dargent J. Laparoscopic adjustable gastric banding: lessons from the first 500 patients in a single institution. Obes Surg 1999;9:446-52.
169. Suter M, Giusti V, Heraief E, Jayet C, Jayet A. Early results of laparoscopic gastric banding compared with open vertical banded gastroplasty. Obes Surg 1999;9:374-80.
170. Abu-Abeid S, Szold A. Results and complications of laparoscopic adjustable gastric banding: an early and intermediate experience. Obes Surg 1999;9:188-90.
171. Miller K, Hell E. Laparoscopic adjustable gastric banding: a prospective 4-year follow-up study. Obes Surg 1999;9:183-7.
172. Forsell P, Hallerback B, Glise H, Hellers G. Complications following Swedish adjustable gastric banding: a long-term follow-up. Obes Surg 1999;9:11-6.
173. Doherty C, Maher JW, Heitshusen DS. Prospective investigation of complications, reoperations, and sustained weight loss with an adjustable gastric banding device for treatment of morbid obesity. J Gastrointest Surg 1998;2:102-8.
174. Forestieri P, Meucci L, De Luca M, Formato A, De Werra C, Chiacchio C. Two years of practice in adjustable silicone gastric banding (LAP-BAND): evaluation of variations of body mass index, percentage ideal body weight and percentage excess body weight. Obes Surg 1998;8:49-52.
175. Forsell P, Hellers G. The Swedish Adjustable Gastric Banding (SAGB) for morbid obesity: 9 year experience and a 4-year follow-up of patients operated with a new adjustable band. Obes Surg 1997;7:345-51.
176. Horchner R, Tuinebreijer W. Improvement of physical functioning of morbidly obese patients who have undergone a Lap-Band operation: one-year study. Obes Surg 1999;9:399-402.
177. Doldi SB, Micheletto G, Lattuada E, Zappa MA, Bona D, Sonvico U. Adjustable gastric banding: 5-year experience. Obes Surg 2000;10:171-3.
178. Weiner R, Datz M, Wagner D, Bockhorn H. Quality-of-life outcome after laparoscopic adjustable gastric banding for morbid obesity. Obes Res 1999;9:539-45.
179. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA 1999;282:1523-9.
180. Friedman LM, Furberg CD, DeMets DL. Fundamentals of Clinical Trials, 3rd ed. New York: Springer; 1998.
181. Jadad A. Randomized Controlled Trials. London: BMJ Books; 1998.
182. 2002 Drug Topics Red Book: The Pharmacist's Trusted Companion for More Than a Century. Montvale, NJ: Medical Economics Company; 2002.
[a] McTigue: Departments of Medicine and Epidemiology, 3459 5th Avenue, Suite 933 West/MUH, Pittsburgh, PA.
[b] Harris: Department of Medicine and Cecil G. Sheps Center for Health Services Research, University of North Carolina School of Medicine, Chapel Hill, NC.
[c] Hemphill: Albuquerque, NM.
[d] Lux: RTI International, Research Triangle Park, NC.
[e] Sutton: RTI International, Research Triangle Park, NC.
[f] Bunton: Cecil G. Sheps Center for Health Services Research, University of North Carolina School of Medicine, Chapel Hill, NC.
[g] Lohr: RTI International, Research Triangle Park, NC.
This document is in the public domain within the United States. For information on reprinting, contact Randie Siegel, Director, Division of Printing and Electronic Publishing, Agency for Healthcare Research and Quality, 540 Gaither Road, Rockville, MD 20850. Requests for linking or to incorporate content in electronic resources should be sent to info@ahrq.gov.
Source: McTigue K, Harris R, Hemphil B, Lux L, Sutton S, Bunton AJ, Lohr KN. Screening and Interventions for Obesity in Adults. Summary of the Evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2003;139(11):933-49.
Current as of December 2003
Internet Citation:
McTigue K, Harris R, Hemphil B, Lux L, Sutton S, Bunton AJ, Lohr KN. Screening and Interventions for Obesity in Adults. Summary of the Evidence. Originally published in Ann Intern Med 2003;139(11):933-49. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/clinic/3rduspstf/obesity/obessum.htm
Return to USPSTF Recommendations
U.S. Preventive Services Task Force (USPSTF)
Clinical Information
AHRQ Home Page